Mefloquine/Lariam®

• Policies and Directives
  • DoD / Joint Forces
  • Army
  • VA (Veterans Administration)
• Clinical Guidance
• Fact Sheets
• Other Related Information
• Research
• Related Links

Policies and Directives

DoD / Joint Forces

• ASD Message, Update on Lariam - An Important Anti-Malaria Drug, 17 Jun 04
  
  
• AFEB Memorandum, Armed Forces Epidemiological Board (AFEB) Select Subcommittee to Develop Mefloquine Study Options, 21 May 04
  
  
• AFEB Memorandum, Antimalarials and Current Practice in the Military - 2003 - 13, 31 Jul 03
  
  

Army

• DASG Memorandum, Updated Guidance on Use of Mefloquine (Lariam® ) for Malaria Prophylaxis, 2 Feb 09



• Army G1, Personnel Policy Guidance (PPG) for Contingency Operations in Support of GWOT paragraph 7-6c(1) Malaria Chemoprophylaxis



• OTSG Memorandum, Additional Patient Information to Accompany Each Prescription of Mefloquine (Lariam®), 20 Nov 03 (Superseded)
  
  
• OTSG Memorandum, Updated Health Care Provider Information on Use of Mefloquine Hydrochloride (Lariam®) for Malaria Prophylaxis, 3 Oct 02 (Superseded)
  
  

VA (Veterans Administration)

• IL 10-2004-007, Possible Long-Term Health Effects from the Malarial Prophylaxis Mefloquine (Lariam), 23 Jun 04

Back to top

Clinical Guidance